콜포스코프 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 모달리티별, 용도별, 휴대성별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Colposcope Market Growth & Trends:

The global colposcope market size is anticipated to reach USD 537.1 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.7% from 2025 to 2030. Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth. According to the ICO Information Centre on HPV and Cancer, cervical cancer is the fourth most frequent cancer among women globally, with an estimated 604,127 new cases and 341,831 deaths in 2020.

An article published by the Human Papillomavirus Information Center stated that cervical cancer is reported to be the second most common cancer among women aged 15 to 44. Colposcopy helps in accurate identification of cervical pre-cancer and early invasive cancer. Moreover, colposcope directed biopsies of severe lesion visualized help in further management of the disease. Growing awareness and rise in the number of screening campaigns for cervical cancer conducted by governments of various regions are expected to fuel the market growth during the forecast period.

In the U.S., National Breast and Cervical Cancer Early Detection Program (NBCCEDP) offers breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured women across the country. Several obstacles arose as a result of the COVID-19 pandemic, including logistical constraints, low demand, and reduced sales and marketing activities. However, by mid-2022, the market is predicted to be steadily improving. By encouraging end-users to embrace high-end technologies for early diagnosis of the disease, aiming to lessen cervical cancer cases by 70%, and thus preventing over 4.5 million deaths (Source: WHO). This is expected to significantly boost the market in the coming years.

Colposcope Market Report Highlights:

• The optical colposcopy segment dominated the market and is further expected to continue its dominance over the forecast period, as the adoption of optical colposcope is high in developing regions
• The video colposcope segment is expected to grow at the fastest rate during the forecast period
• Based on application, the oral examination segment is expected to grow the fastest rate during the forecast period.
• Based on portability, the handheld segment is estimated to register the fastest growth rate during the forecast period, owing to its ease of use and compact nature
• The hospital segment held the largest revenue share based on end-use in 2024
• North America dominated the market and accounted for the largest revenue share in 2024
• In Asia Pacific, the market is anticipated to witness the fastest CAGR over the forecast period owing to the growing need for technologically advanced and cost-effective healthcare solutions

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. Portability
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Application outlook
  • 2.2.3. Portability outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Colposcope Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of cervical cancer
    • 3.2.1.2. Rising adoption of early diagnostic techniques
  • 3.2.2. Market restraint analysis
• 3.3. Colposcope Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Colposcope Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Colposcope Modality Market Movement Analysis
• 4.3. Global Colposcope Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 4.4. Optical
  • 4.4.1. Optical market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Video
  • 4.5.1. Video market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Colposcope Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Colposcope Indication Market Movement Analysis
• 5.3. Global Colposcope Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Pelvic
  • 5.4.1. Pelvic market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Oral
  • 5.5.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Colposcope Market: Portability Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Colposcope Indication Market Movement Analysis
• 6.3. Global Colposcope Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Handheld
  • 6.4.1. Handheld market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Stationary
  • 6.5.1. Stationary market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Colposcope Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Colposcope End Use Market Movement Analysis
• 7.3. Global Colposcope Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals' market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Diagnostic Centers
  • 7.5.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Gynecology Clinic
  • 7.6.1. Gynecology clinic market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Specialty Clinic
  • 7.7.1. Specialty clinic market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Ambulatory Surgical Centers
  • 7.8.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. Academic & Research
  • 7.9.1. Academic & research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Colposcope Market: Regional Estimates & Trend Analysis By Modality, Indication, End Use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework/ reimbursement structure
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework/ reimbursement structure
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. Regulatory framework/ reimbursement structure
  • 8.6.2. UK
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework/ reimbursement structure
    • 8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework/ reimbursement structure
    • 8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework/ reimbursement structure
    • 8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework/ reimbursement structure
    • 8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework/ reimbursement structure
    • 8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework/ reimbursement structure
    • 8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework/ reimbursement structure
    • 8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Key country dynamics
    • 8.6.9.2. Competitive scenario
    • 8.6.9.3. Regulatory framework/ reimbursement structure
    • 8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Regulatory framework/ reimbursement structure
  • 8.7.2. Japan
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework/ reimbursement structure
    • 8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. China
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework/ reimbursement structure
    • 8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. India
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework/ reimbursement structure
    • 8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. Australia
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework/ reimbursement structure
    • 8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. South Korea
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework/ reimbursement structure
    • 8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1. Key country dynamics
    • 8.7.7.2. Competitive scenario
    • 8.7.7.3. Regulatory framework/ reimbursement structure
    • 8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Regulatory framework/ reimbursement structure
  • 8.8.2. Brazil
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework/ reimbursement structure
    • 8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Mexico
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework/ reimbursement structure
    • 8.8.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. Argentina
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework/ reimbursement structure
    • 8.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. Regulatory framework/ reimbursement structure
  • 8.9.2. South Africa
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework/ reimbursement structure
    • 8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework/ reimbursement structure
    • 8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework/ reimbursement structure
    • 8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1. Key country dynamics
    • 8.9.5.2. Competitive scenario
    • 8.9.5.3. Regulatory framework/ reimbursement structure
    • 8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2023
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. Karl Kaps GmbH & Co. KG
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Product benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. CooperSurgical, Inc
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Product benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. DYSIS Medical Inc
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Product benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. ATMOS Medizin Technik GmbH & Co. KG
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Product benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Olympus Corporation
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Product benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. McKesson Medical-Surgical Inc.
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Product benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Ecleris
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Product benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Optomic
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Product benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Seiler Instrument Inc.
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Product benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. Symmetry Surgical Inc.
    • 9.6.10.1. Company overview
    • 9.6.10.2. Financial performance
    • 9.6.10.3. Product benchmarking
    • 9.6.10.4. Strategic initiatives

Chapter 10. Analyst Perspective